New Treatment for Knee Osteoarthritis Shows Promise

Knee osteoarthritis can be exceptionally painful and challenging to manage, often resulting in the wearing away of cartilage surrounding the bones. In severe cases, surgical intervention, like knee replacement, may be necessary to alleviate the pain.

This condition is, after all, the most prevalent form of arthritis and affects hundreds of millions of people across the globe.

In response to this growing health issue, researchers from Charité – Universitätsmedizin Berlin in Germany have developed a new treatment that is minimally invasive, safe, and surprisingly effective.

The method revolves around genicular artery embolization (GAE), which targets the abnormal blood vessels and pain-sensing nerves linked with osteoarthritis. The idea is to block these blood vessels, leading to a reduction in nerve activity and pain.

While GAE isn’t a new procedure, the materials used to obstruct the blood vessels in this recent study are still developing. Previously, antibiotics had been used, which raised concerns about potential inflammation and the issue of antibiotic resistance. This study, however, utilized microscopic gel beads that slowly dissolve in the bloodstream.

According to radiologist Florian Nima Fleckenstein from Charité, “GAE represents a new treatment strategy that addresses the abnormal blood vessel growth around the joint, effectively changing the pathological environment associated with osteoarthritis.” He added that by alleviating both inflammation and pain, this method may alter the disease’s trajectory and slow its progression.

The resorbable microspheres are administered directly into the knee without requiring extensive preparation or a prolonged hospital stay. They specifically block blood flow to the problematic blood vessels and nerves associated with osteoarthritis, leaving overall knee circulation intact.

This embolization isn’t permanent; the gel beads dissolve within hours, but they help disrupt the harmful cycle of inflammation and joint pain.

Fleckenstein highlighted that “By targeting the problematic vessels, we can normalize both the blood vessel arrangement and the nerve structure in the knee.” In their study group, participants experienced a noteworthy reduction in pain alongside significant improvements in physical function and quality of life.

The study included 194 participants, averaging 69 years old, who had not found relief through other treatments like physiotherapy or anti-inflammatory medications. Initially, their pain intensity averaged 7 out of 10, but by the study’s conclusion, it dropped to 3 out of 10. Improvements were noted in daily activities, engagement in sports, and overall quality of life, with no significant side effects reported.

Fleckenstein remarked that these findings hold considerable weight due to their basis in real-world data. He believes the treatment could provide long-lasting relief following a single, minimally invasive procedure, serving as a viable alternative to either injections or joint replacement.

Although the study lacked a control group and all subjects came from a single hospital, the consistent effectiveness of the treatment is quite encouraging and warrants further investigation.

Future research could involve larger groups over longer durations, potentially leading to a controlled clinical trial to validate its efficacy compared to alternative treatments or placebo methods.

There remains more work ahead, but together with other emerging therapies, there’s newfound hope for addressing this debilitating condition.

Fleckenstein noted that “For numerous patients suffering from knee osteoarthritis, there’s a significant treatment gap today.” Many find that conservative options like injections no longer provide adequate relief, while joint replacements may not be suitable for various personal or medical reasons.

This research has been published in Radiology.